Biomerica Balance Sheet

Financials in millions USD. Fiscal year is June - May.

Millions USD. Fiscal year is Jun - May.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 28, 2026	May '25 May 31, 2025	May '24 May 31, 2024	May '23 May 31, 2023	May '22 May 31, 2022	May '21 May 31, 2021
Cash & Equivalents	1.34	2.4	4.17	9.72	5.92	4.2
Cash & Short-Term Investments	1.34	2.4	4.17	9.72	5.92	4.2
Cash Growth	-56.31%	-42.47%	-57.09%	64.26%	40.90%	-51.40%
Accounts Receivable	0.94	0.73	0.95	0.72	0.77	1.46
Inventory	1.65	1.49	2.38	2.06	2.42	3.21
Other Current Assets	0.2	0.26	0.24	0.3	0.32	0.37
Total Current Assets	4.12	4.88	7.73	12.8	9.43	9.23
Net Property, Plant & Equipment	0.27	0.56	0.94	1.25	1.52	1.86
Other Intangible Assets	0.23	0.23	0.21	0.17	0.17	0.29
Long-Term Investments	0.17	0.17	0.17	0.17	0.17	0.17
Other Long-Term Assets	0.09	0.11	0.2	0.08	0.1	0.26
Total Assets	4.88	5.95	9.25	14.45	11.37	11.82
Accounts Payable	0.73	0.67	1.14	0.89	0.97	0.58
Accrued Expenses	0.61	0.66	0.66	0.7	0.65	0.39
Current Portion of Leases	0.19	0.36	0.33	0.3	0.34	0.33
Unearned Revenue	0.03	0.06	0.09	0.06	0.05	-
Total Current Liabilities	1.56	1.74	2.2	1.95	2.01	1.3
Long-Term Leases	-	0.1	0.46	0.79	1.04	1.29
Total Long-Term Liabilities	-	0.1	0.46	0.79	1.04	1.29
Total Liabilities	1.56	1.84	2.66	2.73	3.05	2.59
Common Stock	0.24	0.2	0.17	1.35	1.03	0.98
Additional Paid-in Capital	58.98	57.18	54.72	52.71	42.45	38.84
Accumulated Other Comprehensive Income	-0.1	-0.11	-0.1	-0.11	-0.07	-0.05
Retained Earnings	-55.8	-53.17	-48.2	-42.22	-35.08	-30.55
Shareholders' Equity	3.32	4.11	6.59	11.72	8.33	9.23
Total Liabilities & Equity	4.88	5.95	9.25	14.45	11.37	11.82
Total Debt	0.19	0.46	0.79	1.08	1.38	1.62
Net Cash (Debt)	1.14	1.94	3.39	8.64	4.54	2.58
Net Cash Growth	-41.11%	-42.66%	-60.81%	90.33%	75.91%	-62.39%
Net Cash Per Share	0.42	0.84	1.61	4.88	2.87	1.73
Book Value	3.32	4.11	6.59	11.72	8.33	9.23
Book Value Per Share	1.23	1.79	3.13	6.63	5.26	6.19
Tangible Book Value	3.09	3.88	6.38	11.56	8.16	8.93
Tangible Book Value Per Share	1.15	1.69	3.03	6.53	5.15	5.99

SEC Filings: 10-K · 10-Q